STOCK TITAN

DXP Enterprises insider files Form 144 to sell 40,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DXP Enterprises, Inc. (DXPE) notice states that a person intends to sell 40,000 shares of common stock on or about 09/19/2025. The filing lists the broker as Amegy Bank, 1717 West Loop South, Houston, TX and gives an aggregate market value of $4,729,200 for the shares to be sold. The securities were acquired on 03/01/2017 by open market purchase/equity compensation and paid for in cash. The filing also discloses a prior sale by the same person of 45,938 common shares on 06/30/2025 for $4,030,141. The filer affirms they are not aware of undisclosed material adverse information.

Positive

  • Transparency: The filer provided required disclosure including acquisition date, broker, and aggregate market value
  • Compliance: The notice affirms the seller does not know undisclosed material adverse information

Negative

  • Insider selling: Proposed sale of 40,000 shares valued at $4,729,200 could represent meaningful insider liquidity
  • Recent prior sale: The same person sold 45,938 shares on 06/30/2025 for $4,030,141, indicating multiple sizable sales within the year

Insights

TL;DR: Insider proposes a sizable sale (40,000 shares, $4.73M) following a recent sale (45,938 shares, $4.03M).

The Form 144 is a regulatory notice of proposed sale under Rule 144; it documents the seller's acquisition history and planned transaction logistics without providing any company operational details. For investors, the key takeaways are the size and timing of the proposed sale and the recent sale earlier in the year. This notice alone does not disclose the seller's motivation or whether these sales will materially affect outstanding float or control, but it is a required compliance step that provides transparency about insider liquidity events.

TL;DR: The filing is a routine compliance disclosure showing an insider liquidity event; it raises governance transparency but not operational impact.

The document confirms the seller represented no undisclosed material adverse information at signature. It records acquisition method (open market/equity compensation) and prior recent sales, which governance teams monitor for patterns. The Form 144 itself is procedural and does not assert any change in company strategy or management status.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for DXPE disclose?

The Form 144 discloses a proposed sale of 40,000 common shares scheduled about 09/19/2025, broker details, acquisition date 03/01/2017, and aggregate market value $4,729,200.

Who is the broker handling the proposed DXPE sale?

The filing lists Amegy Bank, 1717 West Loop South, Houston, TX as the broker for the proposed sale.

When were the shares to be sold originally acquired?

The 40,000 shares were acquired on 03/01/2017 via open market purchase/equity compensation and paid in cash.

Has the seller sold DXPE shares recently?

Yes; the filing reports a prior sale of 45,938 shares on 06/30/2025 with gross proceeds of $4,030,141.

Does the Form 144 state any undisclosed material adverse information?

The filer represents by signing the notice that they do not know any material adverse information not publicly disclosed.